Hjem › Epstein-Barr-virusinfeksjoner › Ohio
Kliniske studier for Epstein-Barr-virusinfeksjoner i Ohio
5 studier for Epstein-Barr-virusinfeksjoner søker deltakere på steder i Ohio.
Byer i Ohio
Offisiell studietekst (engelsk)
Donor-Derived Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
RekruttererFase 1/2
4 Weeks · Alle kjønn · Oppdatert 4. sep. 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus
RekruttererFase 2
2 Days · Alle kjønn · Oppdatert 4. sep. 2026 · NCT02532452A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Cleveland Clinic Foundation (Adults and Pediatrics), Cleveland
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (Adults and Pediatrics), Columbus
RekruttererFase 3
Alle aldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT03394365A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05592626EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
- Nationwide Children's Hosptial, Columbus
RekruttererFase 2
1 Month – 79 Years · Alle kjønn · Oppdatert 8. aug. 2025 · NCT03266653Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.